Point72 Asset Management, L.P. - 11 Sep 2025 SCHEDULE 13G Report for Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share
Symbol
DNTH
Shares outstanding
40,021,509 shares
Disclosed Ownership
2,121,140 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
12 Sep 2025, 16:10:13 UTC
Date of event
11 Sep 2025
Previous filing
14 Aug 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 5.3% ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH) on 11 Sep 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G for Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH).
  • Disclosed ownership: 5.3%.
  • Date of event: 11 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 12 Sep 2025, 16:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 5.3% 2,121,140 0 2,121,140 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 5.3% 2,121,140 0 2,121,140 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 5.3% 2,121,140 0 2,121,140 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person